Comprehensive management of risk factors in peripheral vascular disease. Expert consensus
2021; Elsevier BV; Volume: 222; Issue: 2 Linguagem: Inglês
10.1016/j.rceng.2020.11.011
ISSN2254-8874
AutoresVivencio Barrios, Patricia Jiménez Beato, Carlos Brotons, Raquel Campuzano, Juan Francisco Merino-Torres, José María Mostaza, Núria Plana, José Antonio Rubio, Marta Comellas, Ma Dolores Aicart Bort, Fátima Almagro Múgica, Vicente Ignacio Arrarte Esteban, Isabel Ayala Vigueras, A. Barquilla García, Virginia Bellido, Alejandro Berenguel Senén, Agustín Blanco Echevarría, Manuel Antonio Botana López, Ángel Brea Hernando, Miguel Brito Banfiel, Laura Calsina Juscafresa, María Gloria Cánovas Molina, Julio A. Carbayo Herencia, Eduardo Carrasco, Amelia Carro, Marta Casañas, Luis Castilla‐Guerra, J.M. Cepeda Rodrigo, Sergio Cinza‐Sanjurjo, Albert Benet i Clarà, José Manuel Comas Samper, Alberto Cordero, Juan Cosı́n-Sales, Javier de Juan Bagudá, Natalia de la Fuente, Elías Delgado, Esther Dóiz Artázcoz, María Durán Martínez, Javier Escalada, Carlos Escobar Cervantes, Daniel Escribano Pardo, Luis Estallo Laliena, Francisco Javier Félix Redondo, Jacinto Fernández Pardo, Jose María Fernández Rodriguez-Lacin, Juan Carlos Ferrer García, M. Frías Vargas, Andrés Galarza Tapia, Andrés García León, A. García Lerín, Lisardo García-Martín, Manuel Gargallo Fernández, Inés Gil Gil, Juan Girbés Borrás, Mercedes Guerra Requena, Carlos Guijarro, Antonio Miguel Hernández Martínez, S. Hevia, Daiana Ibarretxe Gerediaga, Elena Iborra Ortega, Sergio Jansen Chaparro, Estíbaliz Jarauta Simón, Carlos Jericó Alba, Beatriz Muñoz, Carlos Lahoz, Luís Hernando, Magdalena León Mazorra, María Eugenia López Valverde, R. Calvo, Jorge Jesús Martín Cañuelo, Sergio Martínez‐Hervás, María Ángeles Martínez López, Luís Masmiquel, Ángel Carlos Matía Cubillo, Agustín Medina Falcón, Esther Merino Lanza, Francisco M. Morales-Pérez, Pilar Caridad Morata Barrado, Óscar Moreno, Miren Morillas Bueno, Jose Daniel Mosquera Lozano, Ovidio Muñiz Grijalvo, Núria Muñoz Rivas, María Soledad Navas de Solís, Juan Carlos Obaya, Emilio Ortega, Vicente Pallarés‐Carratalá, Ignacio Párraga Martínez, Vicente Pascual Fuster, Carmen Peinado Adiego, Eva López, Mário Lazaro, Antonio Pérez, Pedro J. Pinés Corrales, José Polo García, M.Á. Prieto Díaz, José Antonio Vazquez, Teresa Martínez, Rebeca Reyes‐García, Tomás Ripoll‐Vera, Enrique Rodilla, Manuel Rodríguez Piñero, Víctor Rodríguez Sáenz de Buruaga, Antonio Ruiz García, Martín Ruiz Ortiz, José Manuel Ruiz Palomar, Adriana Saltijeral Cerezo, Julio Sánchez Álvarez, Ruth Sánchez-Ortiga, Rosa M. Sanchez-Hernández, C. Santos Altozano, María Seoane Vicente, Manuel Suárez Tembra, Cristina Tejera Pérez, Pablo Antonio Toledo Frías, Miguel Turégano Yedro, Pedro Valdivielso, Francisco Valls-Roca, Melina Vega de Céniga, Elisa Velasco Valdazo, Rafael Vidal-Pérez, Alberto Zamora,
Tópico(s)Venous Thromboembolism Diagnosis and Management
ResumoThere is currently a degree of divergence among the main clinical practice guidelines on the management of risk factors for peripheral arterial disease (PAD). This project aims to gain understanding of the management of PAD risk factors in clinical practice and to reach a multidisciplinary consensus on the strategies to be followed in order to optimize its identification, treatment, and follow-up.A multidisciplinary consensus following the Delphi methodology.Professionals (n = 130) with extensive experience in PAD participated in this consultation. The results suggest that in order to optimize the control of risk factors, efforts should be aimed at: (1) promoting the involvement and awareness of all specialists in the identification of and screening for the disease; (2) guaranteeing the possibility of evaluating the ankle-brachial index (ABI) in all the medical specialties involved; (3) promoting strategies for patients to quit smoking through the use of drugs, programs, or referrals to specialized units; (4) promoting an appropriate Mediterranean-based diet and the prescription of daily exercise; (5) raising awareness of the importance of ensuring LDL cholesterol values below 70 mg/dL, especially in symptomatic but also in asymptomatic patients (<55 mg/dL following the publication of the ESC/EAS guide); (6) recommending the use of antiplatelet therapy in asymptomatic patients with diabetes mellitus (DM) and/or a pathological ABI; and (7) protocolizing the annual evaluation of ABI in high-risk patients.This document presents the 22 agreed-upon strategies which are intended to help professionals optimize multidisciplinary management of PAD risk factors.
Referência(s)